Market Overview

OncoMed Announces Encouraging Safety and Anti-Tumor Activity in Demcizumab Phase 1b Clinical Trials at ESMO

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News Events Press Releases

 

Related Articles (OMED)